Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy

Papatheodoridis, George; Lik‐Yuen Chan, Henry; E. Hansen, Bettina; L.A. Janssen, Harry; Lampertico, Pietro

doi:10.1016/j.jhep.2015.01.002

Public

Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy

Published in Journal of Hepatology • Jan 14, 2015

Authors:

George Papatheodoridis

Henry Lik‐Yuen Chan

Bettina E. Hansen

Abstract

In the treatment of chronic hepatitis B (CHB), the ultimate goal is preventing hepatitis B virus (HBV)-associated liver disease, including hepatocellular carcinoma (HCC). Recently published studies show that in CHB patients treated with the currently recommended first-line nucleos(t)ide analogs (NAs...

Subject

Hepatocellular carcinoma

Medicine

Entecavir

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!